-
Rationale and design of the HOVON 170 DLBCL-ANTICIPATE trial: preventing anthracycline-induced cardiac dysfunction with dexrazoxane
Linschoten, M., Geels, J., van Werkhoven, E., Visser-Wisselaar, H., Chamuleau, M. E. D., Teske, A. J., Robbers, L., Oerlemans, S., Crommelin, H., Breems-de Ridder, M., Schut, A., Asselbergs, F. W. & on behalf of the HOVON 170 DLBCL – ANTICIPATE consortium, 1 Dec 2025, In: Cardio-Oncology. 11, 1, 8.Research output: Contribution to journal › Article › Academic › peer-review
-
Effect of trimetazidine dihydrochloride therapy on myocardial external efficiency in pre-clinical individuals with a hypertrophic cardiomyopathy pathogenic variant: results of the ENERGY trial
van Driel, B. O., Schoonvelde, S. A. C., Borodzicz-Jazdzyk, S., Huurman, R., Visch, J., Robbers, L., Harms, H., Verhagen, J., Vermeer, A., van den Aardweg, J., van Rossum, A. C., Germans, T., Michels, M. & van der Velden, J., 1 Oct 2025, In: Cardiovascular Research. 121, 12, p. 1917-1928 12 p.Research output: Contribution to journal › Article › Academic › peer-review
-
Prognostic value of late gadolinium enhancement cardiac MRI for ICD therapy in non-ischaemic cardiomyopathy: A 5-year cohort study
Hopman, L. H. G. A., Becker, M. A. J., de Haas, S. H. M., van der Lingen, A.-L. C. J., Rijnierse, M. T., Bhagirath, P., Zumbrink, M. J. J. M., Olde Nordkamp, L. R. A., Robbers, L. F. H. J., Götte, M. J. W., van Halm, V. P. & Allaart, C. P., 1 May 2025, In: Netherlands Heart Journal. 33, 5, p. 163-171Research output: Contribution to journal › Article › Academic › peer-review
- All publications
